Early Findings about Patient/Staff Infection Rate

 

AATOD asked Board members to provide some preliminary information about patient and staff COVID-19 infection and to report on current conditions in obtaining personal protective equipment (PPE). At the outset, it is important to underscore that the survey was not meant to be scientific in nature. The survey was extremely brief and its intent was to provide a snapshot of patient and staff infection rates. AATOD will be working with research organizations in an effort to obtain more detailed and scientifically accurate data.

Survey Results:
COVID-19 Patient Infection Rates
Twenty-eight (28) Board members responded from the member states of AATOD. The clear majority of the Board members’ programs reported patient infections of 5 or less. Some programs reported zero patient infection. Please keep in mind that these data typically represented information from one or two programs and did not represent statewide reporting. While it is too early to draw any conclusions from such data, it does represent an encouraging finding as of May 15, 2020.
Staff Infections
COVID-19 staff infections also appear to be low. As of May 15, 2020, four AATOD Board members reported comparatively higher staff infection rates in Missouri, Connecticut, Washington State and New York State. Once again, these are early numbers and are expected to change. Additionally, these data do not represent statewide findings. This clearly reflects the risks that are associated among healthcare workers in the OTP environment.
Personal Protective Equipment (PPE)
As many of you know, obtaining personal protective equipment (PPE) for OTPs was a critical challenge in the first four to six weeks of COVID-19 reporting, beginning in mid-March 2020. The HHS/SAMHSA Assistant Secretary, Dr. Elinore McCance-Katz wrote a letter on March 25, 2020, which declared OTPs as essential medical services, providing greater access to personal protective equipment. Director James Carroll of the White House

Office of National Drug Control Policy released a letter on April 23, 2020 to the substance use treatment community, indicating that our treatment facilities represented front line healthcare workers, needing immediate access to PPE. Based on the AATOD informal Board member survey, it would appear that their treatment programs are currently able to obtain personal protective equipment with some exceptions, including face shields and gowns.

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • #aatod2024 ➡️ www.aatodconference.com
  • 💻 Greetings from the  #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 

“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
  • ✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
  • Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
  • AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
  • View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
  • 💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
  • 💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
  • 3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
  • Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
#aatod2024 ➡️ www.aatodconference.com
#aatod2024 ➡️ www.aatodconference.com
2 days ago
View on Instagram |
1/10
💻 Greetings from the  #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 

“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
💻 Greetings from the #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 “Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
2 days ago
View on Instagram |
2/10
✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
✅ Final Reminder 🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024 💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45 📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
3 days ago
View on Instagram |
3/10
Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
Standard Registration Deadline: TOMORROW - Tuesday, April 30, 2024 Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 Register ➡️ aatodconference.com
3 days ago
View on Instagram |
4/10
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️  TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations. We certainly hope that this is helpful and please let us know if you have any questions.
2 weeks ago
View on Instagram |
5/10
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication https://youtu.be/i6u3qUS95jU
3 weeks ago
View on Instagram |
6/10
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW. #ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
3 weeks ago
View on Instagram |
7/10
💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
💻 Webinar Recording is Now Available AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative. We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. ➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
4 weeks ago
View on Instagram |
8/10
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone. Register ➡️ bit.ly/3Vz1RPE
1 month ago
View on Instagram |
9/10
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  REGISTER ➡ https://conta.cc/3TF9CSQ View the final rule ➡ https://lnkd.in/e_iu-AtG. There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW (Director - CSAT’s Division of Pharmacologic Therapies). The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
1 month ago
View on Instagram |
10/10

AVAILABLE 🗒️ TECHNICAL REVIEW OF @SAMHSA’S FINAL REGS ➡️ http://bit.ly/3w71hOM
This brief can be used by treatment providers/state officials as a quick reference in better understanding the salient policy issues in the new regs. We hope that this is helpful.

Load More...

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD